Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
| ▸ | SHBG | P04278 | 1/20 | 0.32 |
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3380518 | 1.00 | ALDH1A1 (0.41) | ALDH1A1EPHX1CA1CA2CA12 | |
| SCHEMBL6073178 | 0.98 | ALDH1A1 (0.42) | ALDH1A1EPHX1CA1CA2 | |
| SCHEMBL3379038 | 0.80 | SHBG (0.39) | EPHX1CA1CA2SHBGTP53 | |
| SCHEMBL1672558 | 0.78 | ALDH1A1 (0.50) | ALDH1A1EPHX1CA1CA2CA12 | |
| SCHEMBL16347556 | 0.78 | CA1 (0.41) | EPHX1CA1CA2CA12CA7 | |
| SCHEMBL9673176 | 0.76 | ALDH1A1 (0.52) | ALDH1A1EPHX1CA1CA12CA7 | |
| SCHEMBL2586909 | 0.73 | SHBG (0.45) | ALDH1A1EPHX1CA1CA12CA7 | |
| SCHEMBL1067752 | 0.72 | ALDH1A1 (0.42) | ALDH1A1EPHX1 | |
| SCHEMBL14779338 | 0.71 | ALDH1A1 (0.52) | ALDH1A1 | |
| SCHEMBL14297001 | 0.71 | ALDH1A1 (0.52) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2120965-B1 | N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES | NOVABAY PHARMACEUTICALS INC (US) | 2014-11-05 | — | — | EP | disclosed |
| EP-2120965-A1 | N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES | Novabay Pharmaceuticals, Inc. (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008083347-A1 | N-HALOGENATED AMINO COMPOUNDS AND DERIVATIVES | NOVABAY PHARMACEUTICALS, INC. (US) | 2008-07-10 | — | — | WO | disclosed |